Effects of immune complexes from SLE patients 731 low concentrations this inhibition showed a doseresponse curve, but the inhibition effect was maximal at 1 ,ug protein/ml IC (1 mg/I) (Fig. 1) . The PEG precipitates, prepared in the same way from a normal sera, showed no significant inhibition. The degree of maximal inhibition varied considerably with ICs from different SLE patients.
The ICs from patients with SLE nephritis inhibited chemotaxis significantly more than the ICs from patients without any renal manifestation (Table 1 ). In contrast disease activity did not alter the effect of the ICs on the monocytes.
The effect of 30 isolated IC samples on monocyte FcR activity was also examined. A 50% inhibition of FcR activity was produced by an IC concentration of 1-01±0*55 ,ug/ml (mean±SD).
The inhibitory effect of the ICs' monocyte chemotaxis and Fc receptor activity were highly correlated (r=0-898) (Fig. 2) .
The isolated ICs were analysed by an ELISA method (Table 2) to test for a correlation between Immune complexes were separated from SLE sera by 3-5% PEG precipitation and gel filtration. (Fig. 3) . The degree of the inhibition was determined neither by the C3 content (r=0.20) nor by the quantity of anti-DNA content (r=0-13). The greatest inhibition of monocyte chemotaxis was seen when ICs were present during the chemotaxis test (Table 3) . When the ICs were removed go. 
Discussion
In experiments presented in this paper the immune complexes isolated from SLE sera inhibited the chemotaxis of healthy monocytes. In separate experiments the possibility that ICs themselves exert a chemotactic activity for monocytes, thereby causing a counter-concentration gradient opposite to the chemotactic factor, was excluded. Data similar to ours were reported by Kay 
